Attovia

Attovia

Clinical-stage biopharma developing biparatopic nanobodies

Overview

Preparing company summary.

About Attovia

Simplify's Rating
Why Attovia is rated
C+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$255M

Headquarters

Fremont, California

Founded

2023

Get referred to Attovia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ATTO-1310 entered Phase 1 trials in January 2025 for chronic pruritus with no approved treatments.
  • ATTO-3712 Phase 1 trials for atopic dermatitis begin in second half of 2025 expanding market access.
  • $90M Series C in April 2025 secures capital to reach clinical proof-of-concept for lead assets.

What critics are saying

  • ATTO-1310 clinical readout failure in chronic pruritus trials likely within 9–12 months with high impact.
  • Goldman Sachs exiting 5%+ stake post-IPO lockup in 6–12 months will cause high valuation compression.
  • Abcam/Novartis biparatopic nanobody platform advancing faster in GPCR targeting within 6–12 months threatens moat.

What makes Attovia unique

  • ATTOBODY™ platform engineers biparatopic nanobodies with ultra-high affinity for hard-to-drug GPCRs.
  • Modular design enables tunable half-lives supporting quarterly or less frequent patient dosing.
  • Spatial positioning technology achieves glue-like off-rates and picomolar affinity exceeding traditional antibodies.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$255M

Above

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$90M
Attovia
$100M
Oura

Benefits

Relocation Assistance

Growth & Insights

Headcount

6 month growth

1%

1 year growth

3%

2 year growth

10%

Recently Posted Jobs

Sign up to get curated job recommendations

Attovia is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →